Riskpilot← Back to searchSign inGet full accessUlla Grane Medicinkonsult AB
ABActiveOrg 5566229109Holländargatan 36Medical specialists activities · NACE 8622Est. 20020 employees
Revenue 2024
SEK 0
EBITDA margin
—
+38% vs 2023
Equity ratio
85.2%
Financial strength
Net profit 2024
SEK -6K
+55% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -8K | +38% |
| Net profit | SEK -6K | +55% |
| Total assets | SEK 132K | -4% |
| Equity | SEK 112K | -5% |
| Employees | 0 | — |
Legal name
Ulla Grane Medicinkonsult AB
Org number
5566229109
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
25 januari 2002
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Grane, Ulla Karin
Company purpose
Bolaget skall bedriva läkarverksamhet, medicinsk konsultation, medicinsk forskning, utbildning inom vård, medicin, ekonomi, samt äga och förvalta fast och lös egendom och därmed förenlig verksamhet.
Address
Holländargatan 36
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 7 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | −0 |
| EBITDA | −11 | −20 | −25 | −13 | −8 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −11 | −20 | −25 | −13 | −8 |
| Net financials | 1 | — | 1 | 1 | 3 |
| Profit before tax | −10 | −20 | −25 | −12 | −6 |
| Tax | −0 | −0 | — | — | — |
| Net profit | −10 | −20 | −25 | −12 | −6 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 193 | 173 | 149 | 137 | 132 |
| Equity | 175 | 155 | 130 | 118 | 112 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 18 | 18 | 19 | 19 | 19 |
| Total debt | 18 | 18 | 19 | 19 | 19 |
EBITDA margin
-815700.0%
This company
15.8%
Market median
-5162758% vs market
20202024
Equity ratio
85.2%
This company
38.2%
Market median
+123% vs market
20202024
Return on equity
-5.0%
This company
18.4%
Market median
-127% vs market
20202024
Net profit margin
-556500.0%
This company
8.1%
Market median
-6870470% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.17×
This company
0.62×
Market median
+73% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Ulla Grane Medicinkonsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ulla Karin Grane | Chairman | 0 companies |
| Ulla Johanna Caroline Grane | Board of Directors | 0 companies |
| Elin Maria Josefine Grane | Board of Directors | 0 companies |